These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2353619)

  • 1. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.
    Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K
    Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine].
    Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K
    Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial ischemia and abnormality of cardiac sympathetic nervous function in apical hypertrophic cardiomyopathy].
    Taniguchi Y; Sugihara H; Terada K; Ito K; Ohtsuki K; Shiga K; Shima T; Nakamura T; Azuma A; Kohno Y
    J Cardiol; 1994; 24(4):293-8. PubMed ID: 8057241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.
    Wichter T; Hindricks G; Lerch H; Bartenstein P; Borggrefe M; Schober O; Breithardt G
    Circulation; 1994 Feb; 89(2):667-83. PubMed ID: 8313555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
    Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M
    Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms.
    Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
    Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial imaging with 123I-MIBG and 201Tl].
    Bunko H; Nakajima K; Hisada K
    Nihon Rinsho; 1991 Jan; 49(1):125-9. PubMed ID: 2002590
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal Evaluation of Sympathetic Nervous System and Perfusion in Normal and Spontaneously Hypertensive Rat Hearts with Dynamic Single-Photon Emission Computed Tomography.
    Zan Y; Boutchko R; Huang Q; Li B; Chen K; Gullberg GT
    Mol Imaging; 2015; 14():373-84. PubMed ID: 26162232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart.
    Taki J; Nakajima K; Bunko H; Simizu M; Muramori A; Hisada K
    Eur J Nucl Med; 1990; 17(5):264-8. PubMed ID: 2128050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic assessment of silent myocardial ischaemia after early infarction using myocardial SPET imaging with 201Tl and 123I-MIBG.
    Shimonagata T; Ishida Y; Hayashida K; Takamiya M; Uehara T; Nishimura T
    Nucl Med Commun; 1995 Nov; 16(11):893-900. PubMed ID: 8587753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Okeie K; Emoto Y; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Nakajima K; Taki J; Mabuchi H
    Clin Cardiol; 2000 May; 23(5):365-70. PubMed ID: 10803446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.
    Shimizu M; Sugihara N; Kita Y; Shimizu K; Horita Y; Nakajima K; Taki J; Takeda R
    Br Heart J; 1992 Feb; 67(2):155-60. PubMed ID: 1540436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.